Cervical Cancer in Ethiopia: The Effect of Adherence to Radiotherapy on Survival

被引:25
|
作者
Moelle, Ulrike [1 ]
Mathewos, Assefa [2 ]
Aynalem, Abreha [2 ]
Wondemagegnehu, Tigeneh [2 ]
Yonas, Bekuretsion [2 ]
Begoihn, Matthias [1 ]
Addissie, Adamu [2 ]
Unverzagt, Susanne [1 ]
Jemal, Ahmedin [3 ]
Thomssen, Christoph [1 ]
Vordermark, Dirk [1 ]
Kantelhardt, Eva J. [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Halle, Saale, Germany
[2] Addis Ababa Univ, Addis Ababa, Ethiopia
[3] Amer Canc Soc, Atlanta, GA 30329 USA
来源
ONCOLOGIST | 2018年 / 23卷 / 09期
关键词
Cervical cancer; Radiotherapy; Sub-Saharan Africa; Survival; Adherence; SQUAMOUS-CELL CARCINOMA; DOSE-RATE BRACHYTHERAPY; RADIATION-THERAPY; UTERINE CERVIX; WORLDWIDE BURDEN; EXTERNAL-BEAM; AFRICA; IRRADIATION; GUIDELINES; EXPERIENCE;
D O I
10.1634/theoncologist.2017-0271
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Discontinuation of radiotherapy (RT) for cervical cancer (CC) in sub-Saharan Africa is common because of patient-and health service-related reasons. This analysis describes toxicities and the effect of adherence on survival. Materials and Methods. A total of 788 patients with CC (2008-2012) who received RT at Addis Ababa University Hospital were included. External beam RT without brachytherapy was performed according to local guidelines. We previously described survival and prognostic factors. Now we analyzed adherence and survival according to total doses received. Adjustment via multivariate cox regression analysis was done. Results. One-year overall survival (OS) after radical RT (n=180) for International Federation of Gynecology and Obstetrics (FIGO) stages IIA-IIIA was 89% for discontinuation (< 72 Gy) and 96% for adherence (>= 72 Gy; hazard ra tio [HR], 1.3; 95% confidence interval [CI], 0.5-3.3). One-year OS after nonradical RT (n=389) for FIGO stages IIIB-IVA was 71% for discontinuation (< 40 Gy) and 87% for adherence (44-50 Gy; HR, 3.1; 95% CI, 1.4-6.9). One-year OS for FIGO stages IIIB-IVB (n=219) after one compared with two or more palliative single fractions of 10 Gy were 14% and 73% respectively (HR, 7.3; 95% CI, 3.3-16). Reasons for discontinuation were toxicities, economic background, and RT machine breakdown. Grade 1-2 late toxicities were common (e.g., 30% proctitis, 22% incontinence). Grade 3 early and late toxicities were seen in 5% and 10% respectively; no grade 4 toxicities occurred. Conclusion. Patients who adhered to guideline-conforming RT had optimum survival. Better supportive care, brachytherapy to reduce toxicities, socioeconomic support, and additional radiation capacities could contribute to better adherence and survival.
引用
收藏
页码:1024 / 1032
页数:9
相关论文
共 50 条
  • [31] The effect of surgery on the survival status of patients with locally advanced cervical cancer after radiotherapy/chemoradiotherapy: a meta-analysis
    Shi, Dan
    Liang, Zhenzhen
    Zhang, Cheng
    Zhang, Huaiyu
    Liu, Xiaodong
    BMC CANCER, 2018, 18
  • [32] Effect of waiting time for radiotherapy on five-year overall survival in women with cervical cancer, 1995-2010
    do Nascimento, Maria Isabel
    Azevedo e Silva, Gulnar
    CADERNOS DE SAUDE PUBLICA, 2015, 31 (11): : 2437 - 2448
  • [33] Survival in cervical cancer
    Suris, JC
    Dexeus, S
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (01) : 11 - 13
  • [34] Cervical cancer in Ethiopia: a review of the literature
    Derbie, Awoke
    Mekonnen, Daniel
    Nibret, Endalkachew
    Misgan, Eyaya
    Maier, Melanie
    Woldeamanuel, Yimtubezinash
    Abebe, Tamrat
    CANCER CAUSES & CONTROL, 2023, 34 (01) : 1 - 11
  • [35] Cervical cancer in Ethiopia: a review of the literature
    Awoke Derbie
    Daniel Mekonnen
    Endalkachew Nibret
    Eyaya Misgan
    Melanie Maier
    Yimtubezinash Woldeamanuel
    Tamrat Abebe
    Cancer Causes & Control, 2023, 34 : 1 - 11
  • [36] Postoperative Radiotherapy for Uterine Cervical Cancer: Impact of Lymph Node and Histological Type on Survival
    Kasuya, Goro
    Ogawa, Kazuhiko
    Iraha, Shiro
    Nagai, Yutaka
    Hirakawa, Makoto
    Toita, Takafumi
    Kakinohana, Yasumasa
    Kudaka, Wataru
    Inamine, Morihiko
    Ariga, Takuro
    Aoki, Yoichi
    Murayama, Sadayuki
    ANTICANCER RESEARCH, 2013, 33 (05) : 2199 - 2204
  • [37] Long-term survival and risk of second cancers after radiotherapy for cervical cancer
    Ohno, Tatsuya
    Kato, Shingo
    Sato, Shinichiro
    Fukuhisa, Kenjiro
    Nakano, Takashi
    Tsuji, Hirohiko
    Arai, Tatsuo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : 740 - 745
  • [38] Analysis of Factors Contributing to the Low Survival of Cervical Cancer Patients Undergoing Radiotherapy in Kenya
    Maranga, Innocent O.
    Hampson, Lynne
    Oliver, Anthony W.
    Gamal, Anas
    Gichangi, Peter
    Opiyo, Anselmy
    Holland, Catharine M.
    Hampson, Ian N.
    PLOS ONE, 2013, 8 (10):
  • [39] Treatment for cervical cancer in Ethiopia: Impact of the optimal radiation dose on survival of 815 patients.
    Woldemariam, Aynalem Abraha
    Moelle, Ulrike
    Woldegeorgis, Mathewos Assefa
    Geberemedhin, Wondemagegnhu Tigeneh
    Yonas, Bekuretsion
    Tufa, Gemechu
    Gebrehiwot, Yirgu
    Trocchi, Pietro
    Vordermark, Dirk
    Thomssen, Christoph
    Addissie, Adamu
    Kantelhardt, Eva Johanna
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Cervical Cancer in Ethiopia: Survival of 1,059 Patients Who Received Oncologic Therapy
    Kantelhardt, Eva Johanna
    Moelle, Ulrike
    Begoihn, Matthias
    Addissie, Adamu
    Trocchi, Pietro
    Yonas, Bekuretsion
    Hezkiel, Petros
    Stang, Andreas
    Thomssen, Christoph
    Vordermark, Dirk
    Gemechu, Tufa
    Gebrehiwot, Yirgu
    Wondemagegnehu, Tigeneh
    Aynalem, Abreha
    Mathewos, Assefa
    ONCOLOGIST, 2014, 19 (07): : 727 - 734